Area of research
Molecular Biology · Pathology and Forensic Medicine
Research interest
Research focused on Cancer research and Lung cancer, with related work in Protein kinase B, FOXM1, Mdm2. Notable publications include 'The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells', 'TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway', and 'miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC'.
USP22 promotes development of lung adenocarcinoma through ubiquitination and immunosuppression
Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
Targeting 14-3-3ζ Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling
Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC
Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling
TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway
miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC
USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma
NF-κB-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers
Overexpression of 14‑3‑3ζ in lung tissue predicts an improved outcome in patients with lung adenocarcinoma
Mammalian Eps15 homology domain 1 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition
14-3-3ζ/TGFβR1 promotes tumor metastasis in lung squamous cell carcinoma
Efficacy and Safety of Nedaplatin in Advanced Breast Cancer Therapy
MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC
USP22 promotes tumor progression and induces epithelial–mesenchymal transition in lung adenocarcinoma
Overexpression of Sphk2 is associated with gefitinib resistance in non-small cell lung cancer
The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
RETRACTED: Ang II–AT1R Increases Cell Migration Through PI3K/AKT and NF‐κB Pathways in Breast Cancer
miR-23a-mediated migration/invasion is rescued by its target, IRS-1, in non-small cell lung cancer cells
ABCC3 as a marker for multidrug resistance in non-small cell lung cancer
Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer
Increased <scp>EHD</scp>1 in non‐small cell lung cancer predicts poor survival